0001949258-23-000001.txt : 20230808 0001949258-23-000001.hdr.sgml : 20230808 20230808161524 ACCESSION NUMBER: 0001949258-23-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230808 DATE AS OF CHANGE: 20230808 EFFECTIVENESS DATE: 20230808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nurture Genomics, Inc. CENTRAL INDEX KEY: 0001949258 IRS NUMBER: 881628016 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-460778 FILM NUMBER: 231151517 BUSINESS ADDRESS: STREET 1: CAMBRIDGE INNOVATION CENTER, 1 BROADWAY CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6179663216 MAIL ADDRESS: STREET 1: CAMBRIDGE INNOVATION CENTER, 1 BROADWAY CITY: CAMBRIDGE STATE: MA ZIP: 02142 D/A 1 primary_doc.xml X0708 D/A LIVE 0001949258 Nurture Genomics, Inc. CAMBRIDGE INNOVATION CENTER, 1 BROADWAY CAMBRIDGE MA MASSACHUSETTS 02142 6179663216 DELAWARE None None Corporation true 2022 Hans Keil Cambridge Innovation Center One Broadway, Kendall Square Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Robert C Green Cambridge Innovation Center One Broadway, Kendall Square Cambridge MA MASSACHUSETTS 02142 Executive Officer Director David Feinberg Cambridge Innovation Center One Broadway, Kendall Square Cambridge MA MASSACHUSETTS 02142 Executive Officer Other Health Care Decline to Disclose 06b true 0001949258-22-000001 2022-09-23 true true true true Simple Agreement for Future Equity false 0 5000000 1705000 3295000 false 20 0 0 250000 true Sale will be used to fund the development of the Company, which heretofore has been funded personally by one or more persons listed in Item 3. A portion of such proceeds (not to exceed 10% of the offering) may be applied to reimbursing such persons. false Nurture Genomics, Inc. /s/ Hans Keil Hans Keil Chief Executive Officer 2023-08-08